MEDIMMUNE SELLS 2.5 MILLION SHARES OF COMMON STOCK
MEDIMMUNE SELLS 2.5 MILLION SHARES OF COMMON STOCK GAITHERSBURG, Md., Dec. 10 /PRNewswire/ -- MedImmune, Inc.
(NASDAQ: MEDI) announced that it has sold 2.5 million shares of common stock priced at $43.50 per share. Of the shares offered, 500,000 shares were sold by the company and 2.0 million shares were sold by selling shareholders. The underwriters for this offering are Morgan Stanley & Co. Incorporated and Smith Barney, Harris Upham & Co. Incorporated. After the offering, MedImmune will have 16.9 million shares of common stock outstanding on a fully diluted basis, prior to any shares sold to cover over-allotments.
MedImmune, Inc. was founded in 1988 to develop, manufacture and market therapeutics and vaccines for the treatment and prevention of certain infectious diseases and cancers. Copies of the prospectus can be obtained from the office of Morgan Stanley & Co. Incorporated, 1251 Avenue of the Americas, New York, N.Y. 10020, or Smith Barney, Harris Upham & Co. Incorporated, 1345 Avenue of the Americas, New York, N.Y. 10105. -0- 12/10/91 /CONTACT: Emilio O. DiCataldo, senior vice president of MedImmune, 301-417-0770, Fred Spar of Kekst and Company, 212-593-2655, for MedImmune/ (MEDI) CO: MedImmune Inc. ST: Maryland IN: MTC SU: OFR SH -- NY014 -- 0888 12/10/91 09:37 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Dec 10, 1991|
|Previous Article:||AFRICAN DEVELOPMENT BANK $200 MILLION SUBORDINATED DEBT RATED "AA+" -- FITCH FINANCIAL WIRE --|
|Next Article:||PENTLAND GROUP PLC TO SELL HOLDING IN REEBOK INTERNATIONAL|